aTyr Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.74	11.06	22.54	9.98	2.34
Short-Term Investments	67.94	61.07	75.62	56.17	105.58
Cash & Short-Term Investments	78.69	72.13	98.17	66.15	107.91
Cash Growth	9.10%	-26.53%	48.41%	-38.70%	240.53%
Other Receivables	0.87	1.74	2.44	11.78	0.44
Total Trade Receivables	0.87	1.74	2.44	11.78	0.44
Other Current Assets	0.68	8.09	2.39	2.95	5.22
Total Current Assets	80.24	81.95	102.99	80.87	113.57
Net Property, Plant & Equipment	10.38	11.86	14.05	11.56	1.81
Other Long-Term Assets	2.38	3.02	3.62	3.36	0.16
Total Assets	93	96.83	120.65	95.79	115.54
Accounts Payable	3.89	4.32	3.53	3.11	1.03
Accrued Expenses	9.79	9.39	11.56	9.86	4
Current Portion of Leases	1.47	1.25	1.33	0.89	0.98
Total Current Liabilities	15.15	14.97	16.42	13.86	6.01
Long-Term Leases	10.57	12.03	13.77	10.64	0.4
Total Long-Term Liabilities	10.57	12.03	13.77	10.64	0.4
Total Liabilities	25.72	27	30.18	24.5	6.41
Common Stock	0.1	0.08	0.06	0.03	0.03
Additional Paid-in Capital	673.55	602.02	558.69	489.5	481.83
Accumulated Other Comprehensive Income	-0.01	-0.04	-0.07	-0.43	-0.26
Retained Earnings	-606.16	-532.05	-468.02	-417.63	-372.3
Total Common Shareholders' Equity	67.48	70.02	90.66	71.46	109.3
Minority Interest	-0.19	-0.19	-0.19	-0.18	-0.18
Shareholders' Equity	67.29	69.83	90.47	71.28	109.13
Total Liabilities & Equity	93	96.83	120.65	95.79	115.54
Total Debt	12.03	13.28	15.1	11.53	1.38
Net Cash (Debt)	66.65	58.84	83.07	54.61	106.53
Net Cash Growth	13.28%	-29.17%	52.11%	-48.74%	261.74%
Net Cash Per Share	0.72	0.79	1.55	1.92	5.58
Book Value	67.48	70.02	90.66	71.46	109.3
Book Value Per Share	0.73	0.94	1.69	2.51	5.73
Tangible Book Value	67.48	70.02	90.66	71.46	109.3
Tangible Book Value Per Share	0.73	0.94	1.69	2.51	5.73

Updated Mar 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q